Selected research
Industry Research
Microorganisms Development Services Industry Research Report 2026
Market perspective
The global Microorganisms Development Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microorganisms Development Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microorganisms Development Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microorganisms Development Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microorganisms Development Services include BRAIN Biotech, WuXi Biologics, KBI Biopharma, Lonza, Evonik, Lallemand Inc, Creative Biogene, MDG Bio and Creative BioMart Microbe, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Microorganisms Development Services market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microorganisms Development Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microorganisms Development Services Market by Company
BRAIN Biotech
WuXi Biologics
KBI Biopharma
Lonza
Evonik
Lallemand Inc
Creative Biogene
MDG Bio
Creative BioMart Microbe
Meurice R&D
BOC Sciences
Esco Aster
Microorganisms Development Services Segment by Type
Gene Editing and Synthesis Services
Directed Evolution and Screening Services
Metabolic Pathway Reconstruction Services
Fermentation Process Development Services
Others
Microorganisms Development Services Segment by Application
Biopharmaceuticals
Food and Ingredients
Agriculture and Environment
Energy and Materials
Others
Microorganisms Development Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microorganisms Development Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microorganisms Development Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microorganisms Development Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microorganisms Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gene Editing and Synthesis Services
- Directed Evolution and Screening Services
- Metabolic Pathway Reconstruction Services
- Fermentation Process Development Services
- Others
Applications
- Biopharmaceuticals
- Food and Ingredients
- Agriculture and Environment
- Energy and Materials
- Others
Companies covered
- BRAIN Biotech
- WuXi Biologics
- KBI Biopharma
- Lonza
- Evonik
- Lallemand Inc
- Creative Biogene
- MDG Bio
- Creative BioMart Microbe
- Meurice R&D
- BOC Sciences
- Esco Aster
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microorganisms Development Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Gene Editing and Synthesis Services
- 2.2.3 Directed Evolution and Screening Services
- 2.2.4 Metabolic Pathway Reconstruction Services
- 2.2.5 Fermentation Process Development Services
- 2.2.6 Others
- 2.3 Microorganisms Development Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceuticals
- 2.3.3 Food and Ingredients
- 2.3.4 Agriculture and Environment
- 2.3.5 Energy and Materials
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Microorganisms Development Services Breakdown Data by Type
- 3.1 Global Microorganisms Development Services Historic Market Size by Type (2021-2026)
- 3.2 Global Microorganisms Development Services Forecasted Market Size by Type (2027-2032)
4 Microorganisms Development Services Breakdown Data by Application
- 4.1 Global Microorganisms Development Services Historic Market Size by Application (2021-2026)
- 4.2 Global Microorganisms Development Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microorganisms Development Services Market Perspective (2021-2032)
- 5.2 Global Microorganisms Development Services Growth Trends by Region
- 5.2.1 Global Microorganisms Development Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microorganisms Development Services Historic Market Size by Region (2021-2026)
- 5.2.3 Microorganisms Development Services Forecasted Market Size by Region (2027-2032)
- 5.3 Microorganisms Development Services Market Dynamics
- 5.3.1 Microorganisms Development Services Industry Trends
- 5.3.2 Microorganisms Development Services Market Drivers
- 5.3.3 Microorganisms Development Services Market Challenges
- 5.3.4 Microorganisms Development Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microorganisms Development Services Players by Revenue
- 6.1.1 Global Top Microorganisms Development Services Players by Revenue (2021-2026)
- 6.1.2 Global Microorganisms Development Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Microorganisms Development Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microorganisms Development Services Head Office and Area Served
- 6.4 Global Microorganisms Development Services Players, Product Type & Application
- 6.5 Global Microorganisms Development Services Manufacturers Established Date
- 6.6 Global Microorganisms Development Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microorganisms Development Services Market Size (2021-2032)
- 7.2 North America Microorganisms Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microorganisms Development Services Market Size by Country (2021-2026)
- 7.4 North America Microorganisms Development Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microorganisms Development Services Market Size (2021-2032)
- 8.2 Europe Microorganisms Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microorganisms Development Services Market Size by Country (2021-2026)
- 8.4 Europe Microorganisms Development Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microorganisms Development Services Market Size (2021-2032)
- 9.2 Asia-Pacific Microorganisms Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microorganisms Development Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microorganisms Development Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microorganisms Development Services Market Size (2021-2032)
- 10.2 South America Microorganisms Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microorganisms Development Services Market Size by Country (2021-2026)
- 10.4 South America Microorganisms Development Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microorganisms Development Services Market Size (2021-2032)
- 11.2 Middle East & Africa Microorganisms Development Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microorganisms Development Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microorganisms Development Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 BRAIN Biotech
- 12.1.1 BRAIN Biotech Company Information
- 12.1.2 BRAIN Biotech Business Overview
- 12.1.3 BRAIN Biotech Revenue in Microorganisms Development Services Business (2021-2026)
- 12.1.4 BRAIN Biotech Microorganisms Development Services Product Portfolio
- 12.1.5 BRAIN Biotech Recent Developments
- 12.2 WuXi Biologics
- 12.2.1 WuXi Biologics Company Information
- 12.2.2 WuXi Biologics Business Overview
- 12.2.3 WuXi Biologics Revenue in Microorganisms Development Services Business (2021-2026)
- 12.2.4 WuXi Biologics Microorganisms Development Services Product Portfolio
- 12.2.5 WuXi Biologics Recent Developments
- 12.3 KBI Biopharma
- 12.3.1 KBI Biopharma Company Information
- 12.3.2 KBI Biopharma Business Overview
- 12.3.3 KBI Biopharma Revenue in Microorganisms Development Services Business (2021-2026)
- 12.3.4 KBI Biopharma Microorganisms Development Services Product Portfolio
- 12.3.5 KBI Biopharma Recent Developments
- 12.4 Lonza
- 12.4.1 Lonza Company Information
- 12.4.2 Lonza Business Overview
- 12.4.3 Lonza Revenue in Microorganisms Development Services Business (2021-2026)
- 12.4.4 Lonza Microorganisms Development Services Product Portfolio
- 12.4.5 Lonza Recent Developments
- 12.5 Evonik
- 12.5.1 Evonik Company Information
- 12.5.2 Evonik Business Overview
- 12.5.3 Evonik Revenue in Microorganisms Development Services Business (2021-2026)
- 12.5.4 Evonik Microorganisms Development Services Product Portfolio
- 12.5.5 Evonik Recent Developments
- 12.6 Lallemand Inc
- 12.6.1 Lallemand Inc Company Information
- 12.6.2 Lallemand Inc Business Overview
- 12.6.3 Lallemand Inc Revenue in Microorganisms Development Services Business (2021-2026)
- 12.6.4 Lallemand Inc Microorganisms Development Services Product Portfolio
- 12.6.5 Lallemand Inc Recent Developments
- 12.7 Creative Biogene
- 12.7.1 Creative Biogene Company Information
- 12.7.2 Creative Biogene Business Overview
- 12.7.3 Creative Biogene Revenue in Microorganisms Development Services Business (2021-2026)
- 12.7.4 Creative Biogene Microorganisms Development Services Product Portfolio
- 12.7.5 Creative Biogene Recent Developments
- 12.8 MDG Bio
- 12.8.1 MDG Bio Company Information
- 12.8.2 MDG Bio Business Overview
- 12.8.3 MDG Bio Revenue in Microorganisms Development Services Business (2021-2026)
- 12.8.4 MDG Bio Microorganisms Development Services Product Portfolio
- 12.8.5 MDG Bio Recent Developments
- 12.9 Creative BioMart Microbe
- 12.9.1 Creative BioMart Microbe Company Information
- 12.9.2 Creative BioMart Microbe Business Overview
- 12.9.3 Creative BioMart Microbe Revenue in Microorganisms Development Services Business (2021-2026)
- 12.9.4 Creative BioMart Microbe Microorganisms Development Services Product Portfolio
- 12.9.5 Creative BioMart Microbe Recent Developments
- 12.10 Meurice R&D
- 12.10.1 Meurice R&D Company Information
- 12.10.2 Meurice R&D Business Overview
- 12.10.3 Meurice R&D Revenue in Microorganisms Development Services Business (2021-2026)
- 12.10.4 Meurice R&D Microorganisms Development Services Product Portfolio
- 12.10.5 Meurice R&D Recent Developments
- 12.11 BOC Sciences
- 12.11.1 BOC Sciences Company Information
- 12.11.2 BOC Sciences Business Overview
- 12.11.3 BOC Sciences Revenue in Microorganisms Development Services Business (2021-2026)
- 12.11.4 BOC Sciences Microorganisms Development Services Product Portfolio
- 12.11.5 BOC Sciences Recent Developments
- 12.12 Esco Aster
- 12.12.1 Esco Aster Company Information
- 12.12.2 Esco Aster Business Overview
- 12.12.3 Esco Aster Revenue in Microorganisms Development Services Business (2021-2026)
- 12.12.4 Esco Aster Microorganisms Development Services Product Portfolio
- 12.12.5 Esco Aster Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst